English | Español

Technology/Innovation
+ Technology/Innovation
Amanda Rupp | Sep 29, 2016

Sirenas receives funding for nature-inspired therapies
+ Regulatory
John Breslin | Sep 28, 2016

Taxpayers may shoulder financial burden for Obamacare risk corridor program, expert warns
+ Community
John Breslin | Sep 28, 2016

Pallone defends Obamacare, pointing to uninsured rate below 10 percent
+ Regulatory
Amanda Rupp | Sep 27, 2016

FDA launches contest to combat opioid-related deaths
+ Community
Amanda Rupp | Sep 27, 2016

Paralyzed Veterans of America celebrates successful ABLE Awards event
+ Technology/Innovation
Amanda Rupp | Sep 27, 2016

Allele granted NIH funds for Alzheimer’s treatment
+ Regulatory
John Breslin | Sep 27, 2016

Blanket drug price controls branded 'terrible' for innovation by former FDA official
+ Regulatory
Amanda Rupp | Sep 27, 2016

Mullin highlights new law against opioids in Oklahoma

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes